Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Legisym is a private healthcare technology and regulatory compliance company serving the U.S. pharmaceutical supply chain. The company develops and operates software and related services for controlled substance ordering, pharmaceutical license verification, and DSCSA-authorized trading partner credentialing. Its flagship offerings include Express222, a web-based controlled substance ordering system compliant with DEA CSOS requirements, License Verify for automated nationwide pharmaceutical license verification, and Credential Solutions for W3C verifiable credentials aligned with DSCSA workflows. Legisym primarily supports manufacturers, wholesalers, distributors, pharmacies, health systems, and other trading partners that need compliant digital workflows rather than developing therapeutic products. The business appears to be commercial-stage and focused on infrastructure, interoperability, and regulatory operations across pharma distribution and supply-chain compliance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Legisym.